Is Your Government Pricing Process Audit-Ready? Here’s How to Know
Government pricing compliance doesn’t fail all at once. It fails one small gap at a time — a manual AMP calculation here, a missed WAC
Government pricing compliance doesn’t fail all at once. It fails one small gap at a time — a manual AMP calculation here, a missed WAC
Government pricing compliance is one of the highest-stakes challenges in life sciences. Errors in Medicaid Best Price, AMP, or 340B calculations don’t stay contained. They
Federal contracting expectations are changing, again. And this time, the implications for pharmaceutical manufacturers participating in VA and Federal Supply Schedule (FSS) contracting are significant.
Medispend is excited to welcome Chanan Greenberg as General Manager of Revenue Management Solutions, further strengthening the company’s investment in helping life sciences organizations navigate
Legacy systems weren’t built to scale, and the cracks are showing For emerging and mid‑market pharmaceutical companies, growth is the goal. Growth is also the
Washington State has enacted legislation that would require drug manufacturers to report detailed 340B sales and discount data at the state level beginning April 1,
State Price Transparency Reporting (SPTR) has changed quietly, rapidly, and in ways that materially affect pharmaceutical manufacturers. What was once treated as an occasional filing obligation
For years, iContracts set the standard for revenue management in life sciences. Today, we are proud to reintroduce the platform, strengthened through new investment, enhanced
We’re happy to answer any questions you may have and help you determine which of our solutions and services best fit your needs.
We will reach out to you and schedule a call at your convenienceÂ
We have a discovery meeting to discuss your current processes and tools
We prepare a proposal with solutions and services tailored to your unique needs